BTS
PBYI icon

BB&T Securities’s Puma Biotechnology PBYI Stock Holding History

BB&T Securities’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$176K Buy
16,354
+2,957
+22% +$31.9K ﹤0.01% 1530
2019
Q2 		$170K Buy
13,397
+2,499
+23% +$57.5K ﹤0.01% 1548
2019
Q1 		$422K Buy
+10,898
New +$333K ﹤0.01% 1153

Other funds holding PBYI

PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BB&T Securities's PBYI Position: Q3 2019 in Review

BB&T Securities increased its Puma Biotechnology (PBYI) stake by 22% in Q3 2019, buying an estimated $31.9K and bringing the position to 16,354 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

BB&T Securities first reported a position in PBYI in Q1 2019 and has held it in 3 quarters since. The position peaked at $422K in Q1 2019. 144 funds tracked by Wall St. Rank hold PBYI as of Q3 2019.

  • BB&T Securities held 16,354 shares of Puma Biotechnology worth $176K as of Q3 2019.
  • BB&T Securities bought 2,957 Puma Biotechnology shares in Q3 2019, an estimated $31.9K.
  • Puma Biotechnology made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1530 holding.
  • BB&T Securities first reported a position in Puma Biotechnology in Q1 2019 and has held it in 3 quarters since.
  • BB&T Securities's Puma Biotechnology position peaked at $422K in Q1 2019.
  • 144 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.